Gilead Sciences CFO Andrew D. Dickinson Reports Routine RSU Vesting and Tax Withholding
GILEAD SCIENCES, INC.
Subscribe to track GILD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 4 Alert: Gilead Sciences, Inc. ($GILD) Insider: Andrew D. Dickinson (Chief Financial Officer) Transaction: 1,347 shares withheld for taxes at $144.81 ($195,059.07 total value) following the vesting of 2,797 RSUs. Post-Transaction Holdings: 167,096 direct shares Significance: Low (Routine RSU Vesting / Tax Withholding)
Comprehensive Analysis
Insider Transaction Overview
On September 10, 2026, Andrew D. Dickinson, Chief Financial Officer of Gilead Sciences, Inc. ($GILD), executed routine equity compensation transactions reported on Form 4:
- RSU Conversion (Code M): 2,797 Restricted Stock Units vested and converted into 2,797 shares of Common Stock on a 1-for-1 basis at $0.00.
- Tax Withholding (Code F): 1,347 shares of Common Stock were surrendered/withheld to satisfy tax liabilities at a price of $144.81 per share, totaling $195,059.07.
Following these transactions, Mr. Dickinson directly owns 167,096 shares of Gilead Sciences common stock and retains 25,054 unvested Restricted Stock Units.
Significance Assessment
- Trading Significance: Low
- Rationale: These transactions represent routine equity compensation vesting and mandatory share withholding for statutory tax obligations, rather than discretionary open-market buying or selling.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.